Gynaecology News and Research

RSS

Big Ow awareness campaign

When it comes to symptoms of menopause like hot flashes, weight gain or trouble sleeping, chances are most women wouldn't hesitate to speak to their doctor. But there is another common - and equally distressing - effect of menopause that many women just keep to themselves. The Big Ow, also known as vaginal atrophy, will affect as many as two million Canadian women in the next 10 years - but most are too shy or embarrassed to talk about it, even with their doctor.

8 Feb 2010

Submissions invited for 2010 SOGC/CFWH Journalism Awards for Excellence in Women's Health Reporting

The Society of Obstetricians and Gynaecologists of Canada (SOGC), in collaboration with the Canadian Foundation for Women's Health (CFWH), is calling for submissions for the 2010 SOGC/CFWH Journalism Awards for Excellence in Women's Health Reporting.

29 Jan 2010

Preliminary results from Nektar Therapeutics' NKTR-102 Phase 2 study in platinum-resistant ovarian cancer

Nektar Therapeutics today announced preliminary results from the first stage of a two-stage Phase 2 clinical study evaluating NKTR-102 in women with platinum-resistant ovarian cancer. In the first stage of the study, 39 patients enrolled with platinum-resistant disease were evaluable for the primary endpoint of overall response rate using Gynecologic Cancer InterGroup (GCIG) criteria, i.e., a combination of response by tumor imaging

12 Jan 2010

TomTec introduces Image-Arena multimodality platform

TomTec the leading innovator for cardiac imaging presents its next generation Image-Arena™ multimodality platform for Image Analysis, Review and Data Management at the EuroEcho in Madrid.

7 Dec 2009

TomTec Imaging Systems to present new technology for radiologic ultrasound at upcoming RSNA conference

TomTec Imaging Systems, the leading innovator for cardiac image analysis and image management will present its new technology for radiologic ultrasound at the upcoming RSNA conference in Chicago.

26 Nov 2009

TomTec Imaging Systems showcases its new cardiac multimodality workstation at the RSNA

TomTec, the leading innovator for cardiac image analysis and image management, shows its new cardiac multimodality workstation at the RSNA in Chicago!

25 Nov 2009

Positive efficacy data from Phase 2 study of AEZS-108 announced

AEterna Zentaris Inc. (the "Company"), a global biopharmaceutical company focused on endocrine therapy and oncology, today announced positive efficacy data from a Phase 2 study with its targeted cytotoxic peptide conjugate, AEZS-108 (formerly AN-152), in patients with advanced or recurrent endometrial cancer.

25 Nov 2009

Positive data from Æterna Zentaris' Phase 2 targeted cytotoxic peptide conjugate study

Æterna Zentaris Inc., a global biopharmaceutical company focused on endocrine therapy and oncology, today announced positive efficacy data from a Phase 2 study with its targeted cytotoxic peptide conjugate, AEZS-108 (formerly AN-152), in patients with advanced or recurrent endometrial cancer.

24 Nov 2009

New study reveals certain prescription drugs can be harmful to fetus

More than six percent of expectant mothers in Quebec consume prescription drugs that are known to be harmful to their fetuses, according to a Universit- de Montr-al investigation published in the British Journal of Obstetrics and Gynaecology

18 Nov 2009

Maternal blood biomarkers may help predict pregnancy-induced hypertension

A new study that examines the value of maternal blood biomarkers will help identify and monitor patients at risk of developing preeclampsia and is set to change the way expectant mothers are cared for in prenatal clinics around the world.

18 Nov 2009

Does prolonged exposure to paternal antigens protect against pregnancy-induced hypertension?

Faculty of 1000 reviewers examine a study from New Zealand on whether prolonged exposure to the father's semen protects new mothers against pre-eclampsia and having an undersized baby.

13 Nov 2009

Low-level physical activity has beneficial effects on materno-foetal health: Study

Contrary to more conservative customs, exercising up to the end of pregnancy has no harmful effect on the weight or size of the foetus. This is what has been indicated in a study carried out by researchers of the Universidad Polit-cnica de Madrid (Polytechnic University of Madrid), which also shows the positive relationship between the weight of sedentary mothers before pregnancy and the body size of their babies. The conclusions appear in the International Journal of Obesity.

13 Nov 2009

Exercise during pregnancy does not harm the health of foetus

Contrary to more conservative customs, exercising up to the end of pregnancy has no harmful effect on the weight or size of the foetus. This is what has been indicated in a study carried out by researchers of the Universidad Politécnica de Madrid (Polytechnic University of Madrid), which also shows the positive relationship between the weight of sedentary mothers before pregnancy and the body size of their babies.

13 Nov 2009

Environmental factors, obesity and diabetes: Long-term study launched

Three Singapore biomedical institutions have launched a major, long-term study of pregnant mothers and their fetuses as well as infant children to determine just how profoundly environmental factors early in life influence the onset of diseases such as obesity and diabetes in later years.

10 Nov 2009

TivaMed changes its name to Viveve

Women's sexual health company, TivaMed, today announced it has changed its name to Viveve as it prepares for a 2010 launch of its Viveve system to OB/GYNs in select U.S. markets.

9 Nov 2009

Scientific and medical community mourns the loss of Emeritus Professor James Boyer Brown

The scientific and medical community mourns the loss of our esteemed colleague and good friend Emeritus Professor James Boyer Brown AM, MSc (NZ), PhD (Edin), MSc (Melb), DSc (Edin), FRANZCOG (Ad Eundem), Life Member Fertility Society of Australia, Life Member Endocrine Society of Australia, who passed away on Saturday 31st October 2009, aged 90.

4 Nov 2009

IBN iCare to develop cutting-edge nanomaterials for ocular therapy

Marking a significant bench to bedside research milestone in Singapore, the Institute of Bioengineering and Nanotechnology (IBN), the world's first bioengineering and nanotechnology research institute, and the National University Hospital (NUH) launched the IBN iCare and the NUH Eye Centre @ Biopolis at an official opening ceremony officiated by the Senior Minister of State for Trade and Industry and Education, S. Iswaran, at the Biopolis on Nov. 3, 2009.

4 Nov 2009

Positive results from Aeterna Zentaris' AEZS-108 Phase 2 study in ovarian cancer patients

AEterna Zentaris Inc., a global biopharmaceutical company focused on endocrine therapy and oncology, today announced positive efficacy data from a Phase 2 study with its targeted cytotoxic peptide conjugate, AEZS-108 (formerly AN-152), in patients with platinum-resistant and taxane-pretreated ovarian cancer.

2 Nov 2009

Intrauterine contraception is most popular amongst European women

A European study has defined the profile for the usage of long-acting contraceptive methods. The work, presented with the National Congress of Gynaecology award, shows, amongst other things, that 10% of women use these methods, the majority over 30 years old.

29 Oct 2009

Adjuvanted and non-adjuvanted H1N1 vaccines safe for pregnant women, say Canadian experts

After discussion with the Public Health Agency of Canada, and based on the evidence for other adjuvanted vaccines as well as experience around the world to date with the adjuvanted H1N1 vaccine, Canadian experts say that both the adjuvanted and non-adjuvanted H1N1 vaccines are safe for pregnant women.

23 Oct 2009

Gynaecology News and Research

Big Ow awareness campaign

Submissions invited for 2010 SOGC/CFWH Journalism Awards for Excellence in Women's Health Reporting

Preliminary results from Nektar Therapeutics' NKTR-102 Phase 2 study in platinum-resistant ovarian cancer

TomTec introduces Image-Arena multimodality platform

TomTec Imaging Systems to present new technology for radiologic ultrasound at upcoming RSNA conference

TomTec Imaging Systems showcases its new cardiac multimodality workstation at the RSNA

Positive efficacy data from Phase 2 study of AEZS-108 announced

Positive data from Æterna Zentaris' Phase 2 targeted cytotoxic peptide conjugate study

New study reveals certain prescription drugs can be harmful to fetus

Maternal blood biomarkers may help predict pregnancy-induced hypertension

Does prolonged exposure to paternal antigens protect against pregnancy-induced hypertension?

Low-level physical activity has beneficial effects on materno-foetal health: Study

Exercise during pregnancy does not harm the health of foetus

Environmental factors, obesity and diabetes: Long-term study launched

TivaMed changes its name to Viveve

Scientific and medical community mourns the loss of Emeritus Professor James Boyer Brown

IBN iCare to develop cutting-edge nanomaterials for ocular therapy

Positive results from Aeterna Zentaris' AEZS-108 Phase 2 study in ovarian cancer patients

Intrauterine contraception is most popular amongst European women

Adjuvanted and non-adjuvanted H1N1 vaccines safe for pregnant women, say Canadian experts

Viva Saliva Book: The ultimate guide to saliva Book preview Download eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News